A higher dose of Spinraza may be more effective than the currently approved dosing schedule for maintaining motor function in ...

TLX007-CDx was approved by the FDA for PSMA-PET scanning in adult male patients with prostate cancer with suspected ...

Jyong Biotech Ltd. (Revived IPO) (MENS) expects to raise $22 million in an IPO on Wednesday, April 2nd, IPO Scoop reports. The company plans to issue 2,700,000 shares at $7.50-$8.50 per share. The ...

The Centers for Disease Control and Prevention has added a new vaccine recommendation for adults. Those as young as age 50 should get vaccinated against pneumococcal pneumonia, the CDC said. The ...

Washington University-led research shows a small group of participants in an Alzheimer’s study experienced a significant ...

A metro Phoenix city was named the eighth happiest in the United States, according to a WalletHub study. How did your city ...

More consistent accumulation demonstrated in bloodstream over a one-week duration with once-daily DehydraTECH-tirzepatide oral capsules as compared to once-weekly injection of Zepbound® As previously ...

Louisiana is scheduled to carry out its first execution in 15 years this week, barring a last-minute reprieve from the U.S.

An indigenously developed gene therapy for specific blood cancers has shown a 73 per cent response rate among patients in ...

Arizona State Retirement System increased its position in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free ...

IndusInd Bank is in healthy condition despite a recent market cap decline, says Chairman Ashok Hinduja. He assures promoter ...

Nifty Next 50 is fast emerging as a high-growth, high-momentum play for investors looking to invest in large-cap stocks. Positioned as India's junior benchmark for big-cap stocks, this index gained ...